Trump denounces ‘conspiracy’ to delay post-election vaccine

The outgoing president, Donald Trump, who has not yet accepted his defeat in the elections on November 3, blamed, without evidence, an alleged conspiracy that the preliminary data of the vaccine for COVID-19 were not published until after the elections to harm him and accused the pharmaceutical company Pfizer.

The president, visibly angry, attacked the pharmaceutical company and did not accept questions from journalists.

“I was put here to do a job, and Pfizer and others were going ahead with vaccines, you wouldn’t have a vaccine for another four years if it weren’t for me, because the FDA (US regulator) would never have been able to do what they have done if I hadn’t forced them to do it, ”Trump began.

“And Pfizer and others even decided not to evaluate the results of their vaccine, in other words, they did not release a vaccine until after the election,” he denounced without providing evidence. That is why I did to favor nations ”.

So Trump developed a bizarre theory that Pfizer “and others” deliberately decided not to release preliminary data on their vaccine in October, as the outgoing president claimed they planned.

“They decided to delay them because of what I’m doing, and that’s fine with me, because frankly this is something very big, very big, I don’t know if anyone is going to appreciate it, so they waited, waited and waited and thought they were going to come out in a few days after the elections, it would probably have had an impact, who knows?

From there, Trump began to mix his theories of alleged missing ballots in his favor, with “the corrupt games” of the Democrats “and the result of the presidential elections, in which his rival, Joe Biden, won.

During the campaign for the elections, the now outgoing president reiterated on several occasions that the vaccine against COVID-19 would be ready by the date of the elections on November 3.

However, officials from his Administration had estimated that it could be ready by the end of the year or early 2021.

White House epidemiologist Anthony Fauci indicated at the time that the vaccine would likely not be widely available to all Americans until well into 2021.

Pfizer and its German partner BioNTech on Friday requested emergency authorization from the FDA to begin distributing its vaccine, which could be supplied to at-risk populations from December.

Pfizer has not used funds from the US Government for the development of the vaccine, which it has financed out of its pocket, although it has reached an agreement with Washington worth almost 1.95 billion dollars to provide them with 100 million doses.

For its part, the American pharmaceutical company Moderna, which has also presented preliminary results similar to those of Pfizer and could request emergency authorization shortly, does owe part of its success in the historically rapid process to the injection of funds from the United States government. development of the vaccine.